These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20574147)

  • 41. Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis.
    Arnold RJ; Donnelly A; Altieri L; Wong KS; Sung J
    Manag Care Interface; 2007 Feb; 20(2):18-23. PubMed ID: 17405577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different effects of ambulatory blood pressure monitoring on subjective and objective sleep quality.
    Tropeano AI; Roudot-Thoraval F; Badoual T; Goldenberg F; Dolbeau G; Gosse P; Macquin-Mavier I
    Blood Press Monit; 2006 Dec; 11(6):315-20. PubMed ID: 17106315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool.
    Carel K; Bratton DL; Miyazawa N; Gyorkos E; Kelsay K; Bender B; Strand M; Atkins D; Gelfand EW; Klinnert MD
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):500-7. PubMed ID: 19055204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of growth and adiposity from infancy to adulthood in atopic dermatitis.
    Ellison JA; Patel L; Kecojevic T; Foster PJ; David TJ; Clayton PE
    Br J Dermatol; 2006 Sep; 155(3):532-8. PubMed ID: 16911277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.
    Fishbein AB; Lor J; Penedo FJ; Forrest CB; Griffith JW; Paller AS
    J Am Acad Dermatol; 2023 Feb; 88(2):348-356. PubMed ID: 32504726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The course of life of patients with childhood atopic dermatitis.
    Brenninkmeijer EE; Legierse CM; Sillevis Smitt JH; Last BF; Grootenhuis MA; Bos JD
    Pediatr Dermatol; 2009; 26(1):14-22. PubMed ID: 19250399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can actigraphy measure sleep fragmentation in children?
    O'Driscoll DM; Foster AM; Davey MJ; Nixon GM; Horne RS
    Arch Dis Child; 2010 Dec; 95(12):1031-3. PubMed ID: 19850594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. English version of the interim report published in 1998 by the members of the Advisory Committee on Atopic Dermatitis Severity Classification Criteria of the Japanese Dermatological Association.
    Yoshida H; Aoki T; Furue M; Tagami H; Kaneko F; Ohtsuka F; Nishioka K; Toda K; Mizoguchi M; Nakayama H; Ikezawa Z; Takigawa M; Arata J; Yamamoto S; Tanaka Y; Ishigaki M; Kusunoki T; Yoshikawa K
    J Dermatol; 2011 Jul; 38(7):625-31. PubMed ID: 21679229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of sleep in escitalopram-treated female patients with panic disorder.
    Todder D; Baune BT
    Hum Psychopharmacol; 2010 Mar; 25(2):167-73. PubMed ID: 20066671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the sleep/wake cycle in persons with asthma: Three case scenarios.
    Babcock J; Krouse HJ
    J Am Acad Nurse Pract; 2010 May; 22(5):270-7. PubMed ID: 20500742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Grades of severity and the validation of an atopic dermatitis assessment measure (ADAM).
    Charman DP; Varigos GA
    J Outcome Meas; 1999; 3(2):162-75. PubMed ID: 10204325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.
    Angelova-Fischer I; Bauer A; Hipler UC; Petrov I; Kazandjieva J; Bruckner T; Diepgen T; Tsankov N; Williams M; Fischer TW; Elsner P; Fluhr JW
    Br J Dermatol; 2005 Oct; 153(4):767-73. PubMed ID: 16181458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
    Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
    Giordano-Labadie F; Cambazard F; Guillet G; Combemale P; Mengeaud V
    J Dermatolog Treat; 2006; 17(2):78-81. PubMed ID: 16766330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of sleep disturbance associated with atopic dermatitis.
    Kelsay K
    J Allergy Clin Immunol; 2006 Jul; 118(1):198-201. PubMed ID: 16815155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity During Sleep Measured by a Sheet-Shaped Body Vibrometer and the Severity of Atopic Dermatitis in Adults: A Comparison With Wrist Actigraphy.
    Kogure T; Ebata T
    J Clin Sleep Med; 2018 Feb; 14(2):199-204. PubMed ID: 29351828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.